China-based cancer-therapy timing study retracted, fueling anti-China lobbying
Nature Medicine has retracted a high-profile February paper detailing the results of a China-based trial on the timing of cancer therapy, a move that could energize anti-China policymakers and influence debates around immunotherapy timing.